首页> 外文OA文献 >PMH14 ADHERENCE AND PERSISTENCE WITH DULOXETINE VERSUS ESCITALOPRAM AMONG HIGH HEALTH-CARE RESOURCES UTILIZERS WITH MAJOR DEPRESSIVE DISORDER

【2h】

PMH14 ADHERENCE AND PERSISTENCE WITH DULOXETINE VERSUS ESCITALOPRAM AMONG HIGH HEALTH-CARE RESOURCES UTILIZERS WITH MAJOR DEPRESSIVE DISORDER

机译：在患有严重抑郁症的高卫生保健资源使用者中，用度洛西汀对西酞普兰对PMH14的粘附和持久性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Tepper P; Liu X; Able SL; Johnstone B;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases [J] . WangJ., LiuX., MullinsC.D. Current medical research and opinion . 2011,第7期

机译：患有严重抑郁症和慢性疼痛相关疾病的患者使用度洛西汀，文拉法辛XR和依西酞普兰治疗依从性和持续性
2. Adherence and persistence with duloxetine and hospital utilization in patients with major depressive disorder. [J] . Liu X, Tepper PG, Able SL International clinical psychopharmacology . 2011,第3期

机译：重度抑郁症患者对度洛西汀的坚持和坚持以及医院的利用。
3. Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder. [J] . Liu X, Gelwicks S, Faries DE, International clinical psychopharmacology . 2010,第6期

机译：重度抑郁症患者的初始度洛西汀处方剂量和治疗依从性和持续性。
4. Teaching Machines to Know Your Depressive State: On Physical Activity in Health and Major Depressive Disorder [C] . Kun Qian, Hiroyuki Kuromiya, Zixing Zhang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2019

机译：教学机了解您的抑郁状态：健康和重度抑郁症中的体育活动
5. The Effects of Reducing Depressive Severity in Adult Patients Ages 18-65 Diagnosed with Major Depressive Disorder Utilizing Electronic 9-Item Patient Health Questionnaire (PHQ-9) [D] . Okorom, Charles. 2021

机译：减少抑郁严重程度在18-65岁的成人患者中诊断患有电子9项患者健康问卷（PHQ-9）的抑郁症患者
6. Comparing Treatment Persistence Healthcare Resource Utilization and Costs in Adult Patients with Major Depressive Disorder Treated with Escitalopram or Citalopram [O] . Eric Q. Wu, *, Paul E. Greenberg, 2011

机译：依西酞普兰或西酞普兰治疗的重度抑郁症成年患者的治疗持久性医疗资源利用和费用的比较
7. PMH13 ASSOCIATION OF MEDICATION PERSISTENCE AND HEALTH-CARE UTILIZATION IN HIGH-COST PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE OR VENLAFAXINE XR [O] . Liu X, Tepper P, Mullins CD, 2010

机译：接受度洛西汀或文拉法辛XR治疗的伴有严重抑郁障碍的高成本患者PMH13的药物治疗持久性和保健利用

PMH14 ADHERENCE AND PERSISTENCE WITH DULOXETINE VERSUS ESCITALOPRAM AMONG HIGH HEALTH-CARE RESOURCES UTILIZERS WITH MAJOR DEPRESSIVE DISORDER

著录项

相似文献

相关主题

期刊订阅